ABCB11 and Pruritus: Patient 1, who had PFIC2 with BSEP3 subtype mutations, experienced consistent pruritus improvement without consistent reductions in serum bile acid levels or liver function tests while on odevixibat (Table 3, Figure 1 and Figure 2).